# Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors

> **NCT03507244** · PHASE1,PHASE2 · COMPLETED · sponsor: **The First Hospital of Jilin University** · enrollment: 34 (actual)

## Conditions studied

- Leptomeningeal Metastasis

## Interventions

- **DRUG:** Pemetrexed
- **DRUG:** Dexamethasone
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT03507244
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-12
- **Primary completion:** 2019-01-15
- **Final completion:** 2019-07-30
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03507244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03507244, "Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03507244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*